ERBB2 and neoplasm: Moreover, Nbs are being utilized as the antigen-binding domain in Chimeric Antigen Receptor (CAR) T-cell therapy; bispecific CAR-T cells constructed with Nbs targeting HER2 and CD20 have shown promising activity against tumor cells [76,77].